Logo

Biogen Licenses Incyte’s LifeSeq Gold, LifeTools

Jan 28, 2000
Premium

P

ALO ALTO, Calif.--Biogen has licensed the LifeSeq Gold database and LifeTools enterprise-wide data management software from Incyte Pharmaceuticals, which could receive future milestone payments and royalties on sales of products developed with Incyte technology and database information. Financial terms were not disclosed. Used for drug discovery, LifeSeq Gold provides views of genes, their function, and their role in disease development. LifeTools will enable Biogen researchers to process, store, analyze, and manage the ever-growing amounts of genomic data.

Filed under

Informatics
Breaking News
The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.